Detalles de la búsqueda
1.
Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes.
BMC Cancer
; 23(1): 869, 2023 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715134
2.
Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.
Breast Cancer Res Treat
; 196(3): 613-622, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36207619
3.
Identification of a risk prediction model for clinical prognosis in HER2 positive breast cancer patients.
Genomics
; 113(6): 4088-4097, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34666190
4.
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.
JAMA
; 325(1): 50-58, 2021 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33300950
5.
Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study.
Oncologist
; 25(9): e1286-e1291, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32058619
6.
GenCLiP 3: mining human genes' functions and regulatory networks from PubMed based on co-occurrences and natural language processing.
Bioinformatics
; 2019 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31681951
7.
Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer.
Breast Cancer Res Treat
; 173(3): 619-628, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30392113
8.
Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study.
Cancer Res Treat
; 56(2): 513-521, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37846468
9.
Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis.
NPJ Breast Cancer
; 10(1): 45, 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38871705
10.
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.
Breast Cancer (Dove Med Press)
; 16: 223-231, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38628818
11.
Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors.
J Pers Med
; 13(2)2023 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36836599
12.
Construction of immune score and its prognostic value in invasive lobular carcinoma of the breast using computational pathology analysis.
Cancer Med
; 2023 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151972
13.
Construction and validation of a macrophage polarization-related prognostic index to predict the overall survival in patients with early-stage triple-negative breast cancer.
Gland Surg
; 12(2): 225-242, 2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36915811
14.
The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer.
NPJ Breast Cancer
; 9(1): 30, 2023 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37085500
15.
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database.
Cancer Med
; 12(12): 13019-13030, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37096751
16.
BRAF V600E Mutation in Triple-Negative Breast Cancer: A Case Report and Literature Review.
Oncol Res Treat
; 45(1-2): 54-61, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34818649
17.
Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor-Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002).
Clin Cancer Res
; 28(4): 637-645, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34810217
18.
Miller-Payne Grading and 70-Gene Signature Are Associated With Prognosis of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer After Neoadjuvant Chemotherapy.
Front Oncol
; 11: 735670, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34631568
19.
Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer.
Front Oncol
; 11: 747012, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858823
20.
Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.
Drug Des Devel Ther
; 15: 3463-3473, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34408400